Search Results - ICARIA

Impact of oral azithromycin and intermittent preventive treatment with sulfadoxine-pyrimethamine regimen on child mortality in Sierra Leone: trial protocol for a randomised, two-arm, double-blinded, placebo-controlled clinical trial (ICARIA).

Authors: Owusu-Kyei K Chen H Chileshe M et al.

Corporate Authors: Owusu-Kyei K Chen H Chileshe M et al.

Source: Trials [Trials] 2024 Sep 27; Vol. 25 (1), pp. 626. Date of Electronic Publication: 2024 Sep 27.

Publication Type: Clinical Trial Protocol; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies.

Authors: Richardson PG Perrot A Mikhael J et al.

Source: Blood cancer journal [Blood Cancer J] 2024 Nov 28; Vol. 14 (1), pp. 209. Date of Electronic Publication: 2024 Nov 28.

Publication Type: Journal Article; Clinical Trial, Phase III; Validation Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis.

Authors: Sunami K Ikeda T Huang SY et al.

Corporate Authors: Sunami K Ikeda T Huang SY et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Aug; Vol. 22 (8), pp. e751-e761. Date of Electronic Publication: 2022 Apr 08.

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Revised international staging system allocation in the ICARIA-MM study: Practical challenges and impact on outcome.

Authors: Richardson PG Perrot A Takamatsu H

Corporate Authors: Richardson PG Perrot A Takamatsu H

Source: EJHaem [EJHaem] 2021 Nov 07; Vol. 3 (1), pp. 168-170. Date of Electronic Publication: 2021 Nov 07 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101761942 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-6146 (Electronic) Linking ISSN: 26886146 NLM ISO Abbreviation: EJHaem Subsets: PubMed not MEDLINE

A plain language summary of the ICARIA study, comparing isatuximab-pomalidomide- dexamethasone with pomalidomide- dexamethasone in people with multiple myeloma.

Authors: Richardson PG Perrot A San-Miguel J et al.

Source: Future oncology (London, England) [Future Oncol] 2025 Mar; Vol. 21 (6), pp. 653-663. Date of Electronic Publication: 2025 Jan 24.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE; In Process

Viatge al barri d'Icària: El patrimoni viscut d'un passat industrial arxivat.

Authors: Perrone, María Gabriela Navas¹

Source: Catalonian Journal of Ethnology / Revista d'Etnologia de Catalunya. des2018, Issue 43, p258-271. 14p.

Tóxicos: pasado y presente. Pensar históricamente un mundo tóxico: By JOSÉ RAMÓN BERTOMEU SÁNCHEZ. Pp. 160, index. Icaria: Barcelona. 2021. £12.50. ISBN: 978-8-49-888959-8.

Authors: Gil-Farrero, Judit

Source: Ambix Feb2023; Vol. 70 (1).

Journal Info: Publisher: Taylor & Francis Ltd ISSN: 0002-6980

Isatuximab plus pomalidomide and dexamethasone in frail patients with relapsed/refractory multiple myeloma: ICARIA-MM subgroup analysis.

Authors: Schjesvold F Bringhen S G Richardson P et al.

Source: American journal of hematology [Am J Hematol] 2021 Nov 01; Vol. 96 (11), pp. E423-E427. Date of Electronic Publication: 2021 Sep 23.

Publication Type: Clinical Trial, Phase III; Letter; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics.

Authors: Harrison SJ Perrot A Alegre A et al.

Source: British journal of haematology [Br J Haematol] 2021 Jul; Vol. 194 (1), pp. 120-131. Date of Electronic Publication: 2021 May 25.

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Incidence of Diabetes in the Working Population in Spain: Results from the ICARIA Cohort.

Authors: Vazquez, Luis Alberto Calvo-Bonacho, Eva Reviriego, Jesús et al.

Source: Diabetes Therapy. Feb2019, Vol. 10 Issue 1, p57-69. 13p.

Tóxicos Invisibles. La construcción de la ignorancia ambiental: Edited by Ximo Guillem-Llobat and Agustí Nieto-Galan. Pp. 336, illus., index. Icaria: Barcelona. 2020. £19.50. ISBN: 978-84-9888-976-5.

Authors: Correa-Gómez, María José

Source: Ambix Aug2022; Vol. 69 (3).

Journal Info: Publisher: Taylor & Francis Ltd ISSN: 0002-6980

MM-130: Updates from ICARIA-MM, a Phase 3 Study of Isatuximab (Isa) Plus Pomalidomide and Low-Dose Dexamethasone (Pd) vs Pd in Relapsed and Refractory Multiple Myeloma (RRMM).

Authors: Richardson, Paul G. Perrot, Aurore San-Miguel, Jesus et al.

Source: Clinical lymphoma, myeloma & leukemia 2021 Supplement 1; Vol. 21.

Journal Info: Publisher: Elsevier B.V. ISSN: 2152-2650

Poster: MM-130: Updates from ICARIA-MM, a Phase 3 Study of Isatuximab (Isa) Plus Pomalidomide and Low-Dose Dexamethasone (Pd) vs Pd in Relapsed and Refractory Multiple Myeloma (RRMM).

Authors: Richardson, Paul G. Perrot, Aurore San-Miguel, Jesus et al.

Source: Clinical lymphoma, myeloma & leukemia 2021 Supplement 1; Vol. 21.

Journal Info: Publisher: Elsevier B.V. ISSN: 2152-2650

Eratosthenes, Icaria and the Origins of Tragedy.

Authors: Broggiato, Maria¹, maria.broggiato@uniroma1.it

Source: Mnemosyne; 11/15/2014, Vol. 67 Issue 6, p885-899, 15p

Evaluation of isatuximab in patients with soft-tissue plasmacytomas: An analysis from ICARIA-MM and IKEMA.

Authors: Beksac M Spicka I Hajek R et al.

Source: Leukemia research [Leuk Res] 2022 Nov; Vol. 122, pp. 106948. Date of Electronic Publication: 2022 Sep 06.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE

Isatuximab for relapsed/refractory multiple myeloma: review of key subgroup analyses from the Phase III ICARIA-MM study.

Authors: Richardson PG Harrison SJ Bringhen S et al.

Source: Future oncology (London, England) [Future Oncol] 2021 Dec; Vol. 17 (34), pp. 4797-4812. Date of Electronic Publication: 2021 Sep 15.

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

Effect of isatuximab plus pomalidomide/dexamethasone on renal impairment in relapsed/refractory multiple myeloma: ICARIA-MM study subgroup analysis.

Authors: Dimopoulos, Meletios A. Leleu, Xavier Moreau, Philippe et al.

Source: Clinical lymphoma, myeloma & leukemia Oct2019 Supplement; Vol. 19.

Journal Info: Publisher: Elsevier B.V. ISSN: 2152-2650

ICARIA-MM study: efficacy analysis according to prior lines of treatment.

Authors: Bringhen, Sara Attal, Michel Pour, Ludek et al.

Source: Clinical lymphoma, myeloma & leukemia Oct2019 Supplement; Vol. 19.

Journal Info: Publisher: Elsevier B.V. ISSN: 2152-2650

Efficacy of isatuximab/pomalidomide/dexamethasone in relapsed/refractory multiple myeloma: ICARIA-MM high-risk cytogenetics subgroup analysis.

Authors: Harrison, Simon J. Richardson, Paul G. Alegre, Adrian et al.

Source: Clinical lymphoma, myeloma & leukemia Oct2019 Supplement; Vol. 19.

Journal Info: Publisher: Elsevier B.V. ISSN: 2152-2650

Louise Michel, the Paris Commune, and Icaria: Europe's Social Question and the Legacy of French Communalism.

Authors: HARISON, CASEY¹

Source: Communal Societies. 2015, Vol. 35 Issue 2, p159-184. 26p.